Noninvasive Prenatal Testing Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Global Noninvasive Prenatal Testing Market: By Product Type (Instruments and Consumables), By End User (Hospitals, Maternity Clinics, and Diagnostic Centers), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global noninvasive prenatal testing market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

Market Outline: Noninvasive Prenatal Testing Market
Noninvasive prenatal testing is a new type of genetic testing that is used to screen birth defects and inherited diseases. This test is also known as the cell-free DNA screening. The procedures include both non-invasive techniques and invasive techniques. In non-invasive techniques, serum screening and ultrasonography are included. Whereas, in invasive techniques amniocentesis and chorionic villus sampling are included. Most of the healthcare professionals prefer the non-invasive techniques over invasive, as the invasive techniques have higher risk quotient, also sometimes leads to fetal loss. Noninvasive prenatal testing are the innovative testing procedures that uses cell-free circulating fetal DNA in the maternal serum to screen for more common fetal aneuploidies, such as trisomy 21, trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). Increasing prevalence of these genetic disorders are likely to drive the market for non-invasive prenatal testing over the forecast period.

Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/noninvasive-prenatal-testing-market/#ulp-4H8Z4LpNMLEuOnnx

Market Dynamics: Noninvasive Prenatal Testing Market
The rising awareness among parents, adoption toward IVF procedures is driving the market. In birth outcomes such as birth defects, newborn weight, and multiple births, maternal age plays a major role. The average age at which women are giving first birth has been increasing. As per Centre for Disease Control and Prevention (CDC) report, the mean age of a women at first birth was 25.8 years in 2012, and it has increased to 26 years in 2013, in the U.S. In addition to that, according to the World Health Organization (WHO), about 3,000 to 5,000 children are born with chromosome disorder, approximately 60%-80% of the children with Down syndrome have hearing deficit, and 40%-45% have congenital heart disease. The rise in the prevalence of these genetic disorders is likely to drive the market for non-invasive prenatal testing market.


Market Scope: Noninvasive Prenatal Testing Market
The noninvasive prenatal testing market is segmented based on the product type, end user and region
Based on the product type, the market is segmented into the following:
• Instruments
o Microarrays
o Ultrasound Devices
o NGS Systems
o PCR Instruments
o Other Instruments
• Consumables
o Assay Kits &Reagents
o Disposables
Based on the end user, the market is segmented into the following:
• Hospitals
• Maternity Clinics
• Diagnostic Centers

Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/noninvasive-prenatal-testing-market/#ulp-c654SbFYO64MsOhu

Regional Analysis: Noninvasive Prenatal Testing Market
Geographically, global noninvasive prenatal testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America dominates the noninvasive prenatal testing market due to growing adoption of advanced diagnostics in the region and increase in the access to various prenatal testing procedures. North America is expected to hold the largest revenue share over the forecast period. Followed by the North America are the regions of Europe and Asia Pacific. The countries such as India and China are predicted to drive the market in Asia-Pacific region due to favorable population demographics.

Competition Assessment: Noninvasive Prenatal Testing Market
Some of the players in the global noninvasive prenatal testing market include:
• PerkinElmer, Inc. (U.S.)
• QIAGEN N.V. (Germany)
• Becton, Dickinson and Company (U.S)
• Agilent Technologies, Inc. (U.S.)
• Beijing Genomics Institute (China)
• GE Healthcare (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Illumina, Inc. (U.S.)
• Thermo Fisher Scientific, Inc. (U.S.)
• Hoffmann-La Roche Ltd. (Switzerland)
• Pacific Biosciences of California, Inc. (U.S.)

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/noninvasive-prenatal-testing-market/#ulp-14mlyhjMGhVjZqa3

Notable Market Developments: Noninvasive Prenatal Testing Market
• In February 2018, BD (Becton, Dickinson and Company) announced the commercial availability of the CE-IVD marked PAXgene Blood ccfDNA tube within the European Economic Area and Switzerland (Western Europe)

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/noninvasive-prenatal-testing-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

This release was published on openPR.